Charles Riv Labs Intl Com (CRL) Shareholder Sawgrass Asset Management Boosted Stake by $714,420; As Nxp Semiconductors N V Com (NXPI) Share Value Rose, Gabelli Securities Has Trimmed Its Position by $3.07 Million

February 22, 2018 - By Michael Collier

Sawgrass Asset Management Llc increased its stake in Charles Riv Labs Intl Com (CRL) by 89.39% based on its latest 2017Q3 regulatory filing with the SEC. Sawgrass Asset Management Llc bought 6,615 shares as the company’s stock rose 1.24% with the market. The institutional investor held 14,015 shares of the health care company at the end of 2017Q3, valued at $1.51M, up from 7,400 at the end of the previous reported quarter. Sawgrass Asset Management Llc who had been investing in Charles Riv Labs Intl Com for a number of months, seems to be bullish on the $5.07B market cap company. The stock decreased 0.23% or $0.25 during the last trading session, reaching $106.82. About 46,629 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 7.06% since February 22, 2017 and is uptrending. It has underperformed by 9.64% the S&P500.

Gabelli Securities Inc decreased its stake in Nxp Semiconductors N V Com (NXPI) by 5.56% based on its latest 2017Q3 regulatory filing with the SEC. Gabelli Securities Inc sold 27,200 shares as the company’s stock rose 5.22% with the market. The hedge fund held 461,612 shares of the semiconductors company at the end of 2017Q3, valued at $52.20M, down from 488,812 at the end of the previous reported quarter. Gabelli Securities Inc who had been investing in Nxp Semiconductors N V Com for a number of months, seems to be less bullish one the $42.61B market cap company. The stock increased 0.07% or $0.085 during the last trading session, reaching $125.685. About 3.94M shares traded or 17.22% up from the average. NXP Semiconductors N.V. (NASDAQ:NXPI) has risen 24.67% since February 22, 2017 and is uptrending. It has outperformed by 7.97% the S&P500.

Among 17 analysts covering Charles River Laboratories (NYSE:CRL), 8 have Buy rating, 1 Sell and 8 Hold. Therefore 47% are positive. Charles River Laboratories had 45 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was upgraded by Jefferies on Monday, October 9 to “Buy”. As per Monday, January 22, the company rating was downgraded by SunTrust. On Thursday, January 7 the stock rating was upgraded by Wells Fargo to “Outperform”. As per Thursday, August 4, the company rating was maintained by Citigroup. The firm earned “Buy” rating on Thursday, August 31 by Robert W. Baird. Jefferies maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Thursday, August 4 with “Buy” rating. The firm earned “Hold” rating on Friday, July 31 by Deutsche Bank. The stock has “Hold” rating by RBC Capital Markets on Tuesday, February 13. The stock has “Buy” rating by SunTrust on Thursday, November 16. The rating was maintained by Jefferies with “Buy” on Friday, January 8.

Investors sentiment increased to 1.46 in 2017 Q3. Its up 0.09, from 1.37 in 2017Q2. It improved, as 18 investors sold CRL shares while 92 reduced holdings. 55 funds opened positions while 106 raised stakes. 44.95 million shares or 0.15% less from 45.02 million shares in 2017Q2 were reported. Fisher Asset Limited Liability Co reported 452,156 shares stake. 46,119 were accumulated by Legal & General Grp Inc Public Limited Liability Corp. The Illinois-based Envestnet Asset Management has invested 0% in Charles River Laboratories International, Inc. (NYSE:CRL). Moreover, Ny State Common Retirement Fund has 0.02% invested in Charles River Laboratories International, Inc. (NYSE:CRL) for 154,740 shares. Bnp Paribas Asset Sa holds 144,395 shares. 319,324 were accumulated by Fil Ltd. Clarivest Asset Mgmt Limited Liability Com reported 0.24% in Charles River Laboratories International, Inc. (NYSE:CRL). Prelude Cap Management Limited Co accumulated 3,039 shares or 0.03% of the stock. Magnetar Financial Ltd Limited Liability Company accumulated 0.02% or 7,796 shares. Credit Suisse Ag holds 118,173 shares. 4,326 are held by Private Na. Putnam Investments Limited Liability Com holds 0.02% or 68,495 shares. Eagle Boston Invest owns 86,418 shares. Lombard Odier Asset Management (Usa) Corp reported 0.15% in Charles River Laboratories International, Inc. (NYSE:CRL). Oak Associate Oh reported 0.23% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL).

Sawgrass Asset Management Llc, which manages about $3.30 billion and $2.05B US Long portfolio, decreased its stake in 3M Co (NYSE:MMM) by 21,180 shares to 129,447 shares, valued at $27.17 million in 2017Q3, according to the filing. It also reduced its holding in Cooper Cos Inc Com New (NYSE:COO) by 18,660 shares in the quarter, leaving it with 108,745 shares, and cut its stake in Schein Henry Inc Com (NASDAQ:HSIC).

Since September 5, 2017, it had 0 insider buys, and 7 sales for $4.79 million activity. $4,945 worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by FOSTER JAMES C on Thursday, February 15. 3,639 shares were sold by Smith David Ross, worth $396,899 on Friday, February 16. 2,872 shares valued at $312,172 were sold by CHUBB STEPHEN D on Thursday, February 15. The insider Molho Davide sold 6,165 shares worth $678,150.

Gabelli Securities Inc, which manages about $1.30B and $867.10 million US Long portfolio, upped its stake in Cu Bancorp Calif Com (NASDAQ:CUNB) by 84,442 shares to 371,142 shares, valued at $14.39M in 2017Q3, according to the filing. It also increased its holding in Straight Path Communicatns Icl (NYSEMKT:STRP) by 9,300 shares in the quarter, for a total of 36,861 shares, and has risen its stake in Fortress Investment Group Cl A (NYSE:FIG).

Analysts await NXP Semiconductors N.V. (NASDAQ:NXPI) to report earnings on May, 2. They expect $1.44 earnings per share, down 11.11% or $0.18 from last year’s $1.62 per share. NXPI’s profit will be $488.20M for 21.82 P/E if the $1.44 EPS becomes a reality. After $3.06 actual earnings per share reported by NXP Semiconductors N.V. for the previous quarter, Wall Street now forecasts -52.94% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.